Radix Sophorae flavescentis vs other drugs or herbs: Non‐serious adverse events Maximum
It is very uncertain whether radix Sophorae flavescentis changes proportion of participants with ≥ 1 adverse events considered 'not… compared with other drugs or herbs (very low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Radix Sophorae flavescentis vs other drugs or herbs Proportion of participants with ≥ 1 adverse events considered 'not to be serious' (at maximum · chronic hepatitis B It is very uncertain whether radix Sophorae flavescentis changes proportion of participants with ≥ 1 adverse events considered 'not… compared with other drugs or herbs (very low certainty). Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B (2019) · Cochrane Headline outcomes only | RR 0.86 [0.42, 1.75] | 2 studies · 163 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B 2019 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.